Cargando…
The future is now: beyond first line systemic therapy in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is becoming a worldwide concern due to its rising incidence. Although for the incipient stages there are curative therapies, the advanced disease represents a major provocation for the clinicians. 2008 marked as an important year for the hepatology community with the a...
Autores principales: | Nenu, Iuliana, Breaban, Iulia, Pascalau, Sorana, Bora, Cristina-Nelida, Stefanescu, Horia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797356/ https://www.ncbi.nlm.nih.gov/pubmed/35117106 http://dx.doi.org/10.21037/tcr.2018.11.23 |
Ejemplares similares
-
Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
por: Nenu, Iuliana, et al.
Publicado: (2022) -
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
por: Sparchez, Zeno, et al.
Publicado: (2021) -
Refining Liver Biopsy in Hepatocellular Carcinoma: An In-Depth Exploration of Shifting Diagnostic and Therapeutic Applications
por: Spârchez, Zeno, et al.
Publicado: (2023) -
Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond
por: Feng, Maple Ye, et al.
Publicado: (2022) -
Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?
por: Sparchez, Zeno, et al.
Publicado: (2021)